The role of the Platelet Function Analyzer (PFA)-100 and platelet aggregometry in the differentiation of essential thrombocythemia from reactive thrombocytosis

Thrombosis Research

Volumn 125, Issue 2, 2010, Pages 142-146

  Tsantes, Argirios E ^a   Dimoula, Aikaterini ^b   Bonovas, Stefanos ^c   Mantzios, Georgios ^a   Tsirigotis, Panagiotis ^b   Zoi, Katerina ^d   Kalamara, Eleni ^e   Kardoulaki, Aikaterini ^a   Sitaras, Nikolaos ^b   Travlou, Anthi ^a   Dervenoulas, John ^b   Vaiopoulos, George ^f  

^a IASO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c Hellenic Center for Disease Control and Prevention   (Greece)

^d BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^e PANTEION UNIVERSITY   (Greece)

^f LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Differential diagnosis; Essential thrombocythemia; PFA 100; Platelet aggregation; Reactive thrombocytosis

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ANTIGEN; JANUS KINASE 2; VON WILLEBRAND FACTOR;

ADULT; AGED; AGGREGOMETRY; ANALYZER; ARTICLE; BLOOD CELL COUNT; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION ANALYZER; THROMBOCYTHEMIA; THROMBOCYTOSIS;

ADENOSINE DIPHOSPHATE; ADULT; AGED; BLOOD PLATELETS; COLLAGEN; DIAGNOSIS, DIFFERENTIAL; EPINEPHRINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET COUNT; PLATELET FUNCTION TESTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; THROMBOCYTHEMIA, ESSENTIAL; THROMBOCYTOSIS;

EID: 76649101069     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.06.030     Document Type: Article

References (33)

1. Petrides P.E., and Siegel F. Thrombotic complications in essential thrombocythemia: Clinical facts and biochemical riddles. Blood Cells Mol Dis 36 (2006) 379-384
2. Spivak J.L., and Silver R.T. The revised World Health Organization diagnostic criteria for polycythemia vera, essential thrombocytosis, and primary myelofibrosis: an alternative proposal. Blood 112 (2008) 231-239
3. Schafer A.I. Molecular basis of the diagnosis and treatment of polycythemia vera, essential thrombocythemia. Blood 107 (2006) 4214-4222
4. Schafer A.I. Thrombocytosis. N Engl J Med 350 (2004) 1211-1219
5. Buss D.H., Cashell A.W., O'Connor M., Richards II F., and Case L.D. Occurrence, etiology, and clinical significance of extreme thrombocytosis: a study of 280 cases. Am J Med 96 (1994) 247-253
6. Levine R.L., and Wernig G. Role of JAK-STAT signaling in the pathogenesis of myeloproliferative disorders. Hematol Am Soc Hematol Educ Prog 510 (2006) 233-239
7. Murphy S. Thrombocytosis and thrombocythemia. Clin Haematol 12 (1983) 89-106
8. Wehmeier A., Sudhoff T., and Meierkord F. Relation of platelet abnormalities tothrombosis and hemorrhage in chronic myeloproliferative disorders. Semin Thromb Hemost 23 (1997) 391-402
9. Yamamoto K., Sekiguchi E., and Takatani O. Abnormalities of epinehrine-induced platelet aggregation and adenine nucleotides in myeloproliferative disorders. Thromb Haemost 52 (1984) 292-296
10. Hehlmann R., Jahn M., Baumann B., and Kopcke W.L. Essential thrombocythemia. Clinical characterestics and course of 61 cases. Cancer 61 (1988) 2487-2496
11. Raman B.K., Van-Slyck E.J., Riddle J., Sawdyk M.A., Abraham J.P., and Saeed S.M. Platelet function and structure in myeloproliferative diseases, myelodysplastic syndrome and secondary thrombocytosis. Am J Clin Pathol 91 (1989) 647-655
12. Avram S., Lulu A., Angelescu S., Olteanu N., and Mut-Popescu D. Abnormalities of platelet aggregation in chronic myeloproliferative disorders. J Cell Mol Med 5 (2001) 79-87
13. Ginsburg A.D. Platelet function in patients with high platelet counts. Ann Intern Med 82 (1975) 506-511
14. Cesar J.M., de Miguel D., Garcia Avello A., and Burgaleta C. Platelet dysfunction in primary thrombocythemia using the platelet function analyzer, PFA-100. Am J Clin Pathol 123 (2005) 772-777
15. Tsantes A., Mantzios G., Giannopoulou V., Tsirigotis P., Bonovas S., Rapti E., et al. Monitoring aspirin treatment in patients with thrombocytosis: Comparison of the platelet function analyzer (PFA)-100 with optical aggregometry. Thromb Res 123 (2008) 100-107
16. Vardiman J.W., Harris N.L., and Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 100 (2002) 2292-2302
17. Kundu S.K., Heilmann E.J., Sio R., Carcia C., Davidson R.M., and Ostgaard R.A. Description of an in vitro platelet function analyzer - PFA-100. Semin Thromb Hemost 21 (1995) 106-112
18. Jilma B. Platelet function analyzer - PFA-100: a tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 138 (2001) 152-163
19. Sucker C., Senft B., Scharf R., and Zotz R.B. Determination of von Willebrand factor activity: Evaluation of the HaemosIL assay in comparison with established procedures. Clin Appl Thromb Hemost 12 (2006) 305-310
20. Jones A.V., Kreil S., Zoi K., Waghorn K., Curtis C., Zhang L., et al. Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders. Blood 106 (2005) 2162-2168
21. Bellucci S., Janvier M., and Tobelem G. Essential thrombocythemia: clinical evolutionary and biologic data. Cancer 58 (1986) 2440-2447
22. Griesshammer H., Bangerter M., Sauer T., Wennauer R., Bergmann L., and Heimpel H. Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count. J Intern Med 245 (1999) 295-300
23. Tefferi A., Thiele J., Orazi A., Kvasnicka H.M., Barbui T., Hanson C., et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 110 (2007) 1092-1097
24. Tefferi A. Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukaemia. Semin Hematol 36 (1999) 3-8
25. Mitus A.J., and Schafer A.I. Thrombocytosis and thrombocythemia. Hematol Oncol Clin North Am 4 (1990) 157-178
26. Mayodromo O., Carcamo C., Vecino A.M., Navarro J.L., and Cejar J.M. Arachidonic acid metabolism in platelets of patients with essential thrombocythemia. Thromb Res 78 (1995) 315-321
27. Holme S., and Murphy S. Platelet abnormalities in mteloproliferative disorders. Clin Lab Med 10 (1990) 873-888
28. Mazzucato M., De Marco L., De Angelis V., De Roia D., Bizzaro N., and Casonato A. Platelet membrane abnormalities in myeloproliferative disorders: decrease in glycoproteins Ib and IIb/IIIa complex is associated with deficient receptor function. Br J Haematol 73 (1989) 369-374
29. Breddin H.K. Can platelet aggregometry be standardized?. Platelets 16 (2005) 151-158
30. van Genderen P.J., Michiels J.J., van der Poel-van de Luytgaarde S.C., and van Vliet H.H. Acquired von Willebrand disease as a cause of recurrent mucocutaneous bleeding in primary thrombocythemia: relationship with platelet count. Ann Hematol 69 (1994) 81-84
31. Budde U., and van Genderen P.J. Acquired von Willebrand disease in patients with high platelet counts. Semin Thromb Hemost 23 (1997) 425-431
32. Cattaneo M., Lecchi A., Agati B., Lombardi R., and Zighetti M.L. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion. Thromb Res 96 (1999) 213-217
33. Kittur J., Knudson R., Lasho T., Finke C., Gangat N., Wolanskyj A.P., et al. Clinical correlates of JAK2V617F allele burden in essential thrombocythemia. Cancer 109 (2007) 2279-2284